Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA414574
Max Phase: Preclinical
Molecular Formula: C61H68Cl2N2O15
Molecular Weight: 1140.12
Molecule Type: Small molecule
Associated Items:
ID: ALA414574
Max Phase: Preclinical
Molecular Formula: C61H68Cl2N2O15
Molecular Weight: 1140.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@H]1C(=O)[C@@]2(C)C([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2OC(=O)CCCc1ccc(N(CCCl)CCCl)cc1
Standard InChI: InChI=1S/C61H68Cl2N2O15/c1-36-44(77-57(73)50(69)49(40-18-10-7-11-19-40)64-55(71)41-20-12-8-13-21-41)34-61(74)54(79-56(72)42-22-14-9-15-23-42)52-59(6,53(70)51(76-37(2)66)48(36)58(61,4)5)45(33-46-60(52,35-75-46)80-38(3)67)78-47(68)24-16-17-39-25-27-43(28-26-39)65(31-29-62)32-30-63/h7-15,18-23,25-28,44-46,49-52,54,69,74H,16-17,24,29-35H2,1-6H3,(H,64,71)/t44-,45-,46+,49-,50+,51+,52?,54-,59+,60-,61+/m0/s1
Standard InChI Key: XNTVSBUAIRRCRE-WDSMZVQZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1140.12 | Molecular Weight (Monoisotopic): 1138.3997 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wittman MD, Kadow JF, Vyas DM, Lee FL, Rose WC, Long BH, Fairchild C, Johnston K.. (2001) Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids., 11 (6): [PMID:11277526] [10.1016/s0960-894x(01)00067-1] |
Source(1):